Inmunoterapia en el tratamiento del cáncer de cabeza y cuello - page 16

American Society of Clinical Oncology (ASCO)
2016 Congress Presentations
16
Study
First
Author SCCHN
Presentation
Type
Slide
Range
CheckMate
141
Ferris
Further Evaluations of Nivolumab Versus Investigator’s Choice Chemotherapy for
Recurrent or Metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck
(SCCHN): CheckMate 141
Oral 385-406